Latest

Cancer

This image shows a bottle and some tamoxifen pills.

Featured Neurology Open Neuroscience Articles

·September 17, 2013·4 min read

Mental Fog with Tamoxifen is Real, Scientists Find Possible Antidote

Researchers confirm the mental fogginess produced as a result of taking the cancer drug tamoxifen, is real. They have also discovered an existing drug compound which appears to counteract the effects of this medication.

This is an MRI of patient with cancer in the occipital lobe.

Featured Neurology

·August 12, 2013·3 min read

There’s Life After Radiation for Brain Cells

Researchers suggest neural stem cells could be resistant to radiation. The stem cells could be roused from a hibernation-like state in order to reproduce and generate new cells which have the ability to migrate, replace injured cells and restore lost function.

Brain Cancer Featured

·July 23, 2013·3 min read

Researchers Develop New Approach for Studying Deadly Brain Cancer

Researchers discover a way to adjust the malignancy of glioma brain cancer cells in a newly developed 3D hydrogel. The new material mimics the conditions in the brain.

The image shows a brain slice with glioblastoma cancer.

Brain Cancer Featured

·July 17, 2013·2 min read

Nano Drug Crosses Blood-Brain Tumor Barrier, Targets Brain Tumor Cells and Blood Vessels

An experimental nanotechnology drug crosses the blood-brain barrier and targets brain tumor cells, a new study suggests. The drug also blocks the growth of tumor blood vessels.

The image is a magnetic resonance image (MRI) of a sagittal view revealing a mass in the brain that was later shown to be glioblastoma.

Brain Cancer Featured

·July 1, 2013·3 min read

Brain-Penetrating Particle Attacks Deadly Tumors

Researchers have developed a new approach for treating glioblastoma brain cancer. The findings are shown to extend the life of animals treated for the cancer.

The image shows the DAF-2 mutants with decreased insulin/IGF-1 signalling. The caption best describes the image.

Featured Neurology Open Neuroscience Articles

·July 1, 2013·2 min read

Researchers Have Discovered a New Proteasome Regulatory Mechanism

A new study uncovers a new proteasome regulatory mechanism which could bear significance in the treatment of neurodegenerative diseases and some cancers.

The illustration is a brain slice with advanced stage alzheimer's.

Featured Neurology Neuroscience Videos

·June 28, 2013·5 min read

Scientists View ‘Protein Origami’ to Help Understand, Prevent Certain Diseases

Using sophisticated imaging techniques, researchers observe a molecular protein folding process which could help better understand and treat neurodegenerative diseases and cancers.

The diagram shows head and neck regions associated with cancer.

Brain Cancer Featured

·June 18, 2013·2 min read

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer

Researchers have identified a biochemical pathway in cancer stem cells which are essential for the development of head and neck cancers.

Diagram illustrating the influence of dark-light rhythms on circadian rhythms and related physiology and behavior.

Featured Neuroscience

·June 18, 2013·4 min read

Key Protein is Linked to Circadian Clocks, Helps Regulate Metabolism

A new study reveals how the production of p75NTR protein oscillates in time with the body's natural circadian rhythm and how these oscillations help regulate vital metabolic functions. The findings offer an insight into how circadian rhythm helps maintain the body's overall metabolic health.

A brain slice with glioblastoma multiforme

Brain Cancer Featured

·June 13, 2013·3 min read

Metabolic Molecule Drives Growth Of Aggressive Brain Cancer

Researchers have identified an abnormal metabolic pathway which drives cancer cell growth in particular glioblastoma brain cancer subtypes.

The illustration shows a cut away to the brain areas associated with Alzheimer's disease.

Featured Neurology

·May 10, 2013·3 min read

Cancer Drug Prevents Build-up of Toxic Brain Protein

Using a tiny dose of the leukemia drug nilotinib, researchers halt the accumulation of toxic proteins linked to Parkinson's diseases in the brains of mice.